SignatureFD’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$153 Hold
75
﹤0.01% 3429
2026
Q1
$134 Hold
75
﹤0.01% 3387
2025
Q4
$168 Sell
75
-75
-50% -$197 ﹤0.01% 3312
2025
Q3
$364 Buy
+150
New +$399 ﹤0.01% 3233
2025
Q2
Sell
-150
Closed -$131 3390
2025
Q1
$131 Hold
150
﹤0.01% 3265
2024
Q4
$254 Hold
150
﹤0.01% 3210
2024
Q3
$288 Hold
150
﹤0.01% 3149
2024
Q2
$369 Hold
150
﹤0.01% 3014
2024
Q1
$246 Hold
150
﹤0.01% 3084
2023
Q4
$267 Hold
150
﹤0.01% 3032
2023
Q3
$687 Buy
150
+20
+15% +$191 ﹤0.01% 2984
2023
Q2
$1.46K Buy
130
+25
+24% +$266 ﹤0.01% 2885
2023
Q1
$1.19K Hold
105
﹤0.01% 2944
2022
Q4
$720 Buy
105
+45
+75% +$430 ﹤0.01% 3040
2022
Q3
$1K Buy
+60
New +$522 ﹤0.01% 3011

Other funds holding PROK

SignatureFD's PROK Position: Q2 2026 in Review

SignatureFD held its ProKidney (PROK) position steady in Q2 2026 at 75 shares worth $153. The position accounts for ﹤0.01% of the portfolio, ranked #3429.

SignatureFD first reported a position in PROK in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.46K in Q2 2023. 9 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • SignatureFD held 75 shares of ProKidney worth $153 as of Q2 2026.
  • SignatureFD left its ProKidney share count unchanged in Q2 2026.
  • ProKidney made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3429 holding.
  • SignatureFD first reported a position in ProKidney in Q3 2022 and has held it in 15 quarters since.
  • SignatureFD's ProKidney position peaked at $1.46K in Q2 2023.
  • 9 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.